Oncology Drug Reference Sheet: 5-Fluorouracil

A mainstay of many cancer treatments for decades, 5-fluorouracil injection package inserts were updated in March 2024 through the U.S. Food and Drug Administration’s Project Renewal. The revisions add pharmacogenomics information and a safety warning about severe adverse reactions in patients with DPD deficiency.